Skip to main content
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
22.21
-0.47 (-2.07%)
At close: Mar 5, 2026, 4:00 PM EST
22.51
+0.30 (1.35%)
Pre-market: Mar 6, 2026, 4:05 AM EST

Arcus Biosciences Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
License and Devlopment Services
221.00M 220.00M 241.00M 117.00M 232.00M 226.00M 207.00M 198.00M - - - - - -
License and Devlopment Services Growth
-4.74% -2.65% 16.43% -40.91% 190.00% 169.05% 141.42% 137.31% - - - - - -
Other Collaboration
26.00M 30.00M 31.00M 34.00M 36.00M 37.00M 40.00M 39.00M
Other Collaboration Growth
-27.78% -18.92% -22.50% -12.82% -2.70% 2.78% 11.61% 8.62%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.